Journal
MATRIX BIOLOGY
Volume 32, Issue 5, Pages 234-240Publisher
ELSEVIER
DOI: 10.1016/j.matbio.2013.02.008
Keywords
Heparan sulfate; Heparanase; Extracellular matrix; Tumor microenvironment; Macrophages; Inflammation; Cancer
Categories
Funding
- German Israel Research Foundation (GIF)
- Israel Science Foundation [593/10]
- National Cancer Institute, NIH [RO1-CA106456-09]
- EFSD/Novo Nordisk Award
Ask authors/readers for more resources
Heparanase is the only known mammalian endoglycosidase capable of degrading heparan sulfate glycosaminoglycan, both in extracellular space and within the cells. It is tightly implicated in cancer progression and over the past few decades significant progress has been made in elucidating the multiple functions of heparanase in malignant tumor development, neovascularization and aggressive behavior. Notably, current data show that in addition to its well characterized role in cancer, heparanase activity may represent an important determinant in the pathogenesis of several inflammatory disorders, such as inflammatory lung injury, rheumatoid arthritis and chronic colitis. Nevertheless, the precise mode of heparanase action in inflammatory reactions remains largely unclear and recent observations suggest that heparanase can either facilitate or limit inflammatory responses, when tissue/cell-specific contextual cues may dictate an outcome of heparanase action in inflammation. In this review the involvement of heparanase in modulation of inflammatory reactions is discussed through a few illustrative examples, including neuroinflammation, sepsis-associated lung injury and inflammatory bowel disease. We also discuss possible action of the enzyme in coupling inflammation and tumorigenesis in the setting of inflammation-triggered cancer. (c) 2013 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available